CURE vs. TSLL

Last updated Jun 4, 2026

CURE (Direxion Daily Healthcare Bull 3x Shares) and TSLL (Direxion Daily TSLA Bull 2X ETF) are both Leveraged Equities funds from Direxion. CURE is passively managed, while TSLL is actively managed. Over the past 3 years, CURE returned -0.15%/yr vs 9.79%/yr for TSLL. At a 0.18 correlation, their price movements are largely independent. CURE charges 1.08%/yr vs 0.83%/yr for TSLL.

Performance

CURE vs. TSLL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily TSLA Bull 2X ETF (TSLL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CURE achieves a -18.38% return, which is significantly higher than TSLL's -20.85% return.

CURE

• 1D: 2.17%
• 1M: 4.39%
• YTD: -18.38%
• 6M: -18.70%
• 1Y: 21.60%
• 3Y*: -0.15%
• 5Y*: 0.21%
• 10Y*: 11.65%

TSLL

• 1D: 0.00%
• 1M: 13.88%
• YTD: -20.85%
• 6M: -21.38%
• 1Y: 7.17%
• 3Y*: 9.79%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE vs. TSLL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
CURE Direxion Daily Healthcare Bull 3x Shares	-18.38%	22.55%	-8.47%	-9.40%	5.15%
TSLL Direxion Daily TSLA Bull 2X ETF	-20.85%	-26.80%	99.63%	139.86%	-73.85%

Correlation

The correlation between CURE and TSLL is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (All Time) Calculated using the full available price history since Aug 10, 2022	0.18

CURE vs. TSLL - Sectors Allocation Comparison

Sectors	CURE	TSLL
Healthcare	100.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	100.0%
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	-
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

CURE vs. TSLL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE

CURE Risk / Return Rank: 18
CURE Sharpe Ratio Rank: 16
CURE Sortino Ratio Rank: 19
CURE Omega Ratio Rank: 18
CURE Calmar Ratio Rank: 17
CURE Martin Ratio Rank: 17

TSLL

TSLL Risk / Return Rank: 12
TSLL Sharpe Ratio Rank: 9
TSLL Sortino Ratio Rank: 15
TSLL Omega Ratio Rank: 15
TSLL Calmar Ratio Rank: 10
TSLL Martin Ratio Rank: 10

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE vs. TSLL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily TSLA Bull 2X ETF (TSLL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CURE	TSLL	Difference
Sharpe ratio: Return per unit of total volatility	0.50	0.08	+0.42
Sortino ratio: Return per unit of downside risk	1.03	0.77	+0.26
Omega ratio: Gain probability vs. loss probability	1.12	1.09	+0.02
Calmar ratio: Return relative to maximum drawdown	0.70	0.13	+0.57
Martin ratio: Return relative to average drawdown	1.61	0.27	+1.34
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

CURE vs. TSLL - Sharpe Ratio Comparison

The current CURE Sharpe Ratio is 0.50, which is higher than the TSLL Sharpe Ratio of 0.08. The chart below compares the historical Sharpe Ratios of CURE and TSLL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	CURE	TSLL	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.50	0.08	+0.42
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.00	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.24	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.46	-0.08	+0.54

Drawdowns

CURE vs. TSLL - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum TSLL drawdown of -82.88%. Use the drawdown chart below to compare losses from any high point for CURE and TSLL.

Drawdown Indicators

	CURE	TSLL	Difference
Max Drawdown Largest peak-to-trough decline	-69.19%	-82.88%	+13.69%
Max Drawdown (1Y) Largest decline over 1 year	-31.10%	-54.75%	+23.65%
Max Drawdown (3Y) Largest decline over 3 years	-51.93%	-82.88%	+30.95%
Max Drawdown (5Y) Largest decline over 5 years	-52.23%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-69.19%	—	—
Current Drawdown Current decline from peak	-35.21%	-60.03%	+24.82%
Average Drawdown Average peak-to-trough decline	-18.15%	-53.82%	+35.67%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.43%	26.72%	-13.29%

Volatility

CURE vs. TSLL - Volatility Comparison

The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 11.99%, while Direxion Daily TSLA Bull 2X ETF (TSLL) has a volatility of 24.26%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than TSLL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CURE	TSLL	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.99%	24.26%	-12.27%
Volatility (6M) Calculated over the trailing 6-month period	29.83%	54.47%	-24.64%
Volatility (1Y) Calculated over the trailing 1-year period	43.19%	92.38%	-49.19%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	43.69%	106.87%	-63.18%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	49.51%	106.87%	-57.36%

CURE vs. TSLL - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than TSLL's 0.83% expense ratio.

Dividends

CURE vs. TSLL - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.31%, less than TSLL's 6.46% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
CURE Direxion Daily Healthcare Bull 3x Shares	1.31%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%
TSLL Direxion Daily TSLA Bull 2X ETF	6.46%	5.00%	2.47%	4.44%	1.57%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CURE and TSLL in my portfolio?

CURE and TSLL have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, CURE or TSLL?

TSLL has higher volatility (24.26%) compared to CURE (11.99%). In terms of maximum drawdown, CURE dropped -69.19% vs TSLL's -82.88%.

Which ETF is better, CURE or TSLL?

On 3-year performance, TSLL leads with 9.79% vs -0.15% for CURE. On fees, TSLL is cheaper at 0.83% per year. On volatility, CURE has been the lower-risk option at 11.99%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, CURE or TSLL?

Over the 3-year period, TSLL has performed better with a 9.79% return vs -0.15%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, CURE or TSLL?

TSLL is cheaper with a 0.83% expense ratio, compared with 1.08% for CURE.

Which ETF pays a higher dividend yield, CURE or TSLL?

TSLL has the higher dividend yield at 6.46%, compared with 1.31% for CURE.

What is the main difference between CURE and TSLL?

Their fees differ too: 1.08% for CURE and 0.83% for TSLL.

Which has better risk-adjusted returns?

CURE currently has the higher Sharpe Ratio (0.50 vs 0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.